Novel steroids with pregnane skeleton, pharmaceutical compositions containing them and process for preparing same

PCT No. PCT/HU93/00035 Sec. 371 Date Dec. 8, 1994 Sec. 102(e) Date Dec. 8, 1994 PCT Filed Jun. 8, 1993 PCT Pub. No. WO93/25570 PCT Pub. Date Dec. 23, 1993Novel, therapeutically active 21-aminosteroids of formula (I) (I) with pregnane skeleton, are disclosed wherein two of X, Y and Z are a nitrogen a...

Full description

Saved in:
Bibliographic Details
Main Authors ERZSEBET FRANCSICS NEE CZINEGE, SANSOE GOEROEG, LASZLO SZPORNY, ANNA BOOR NEE MEZEL, SANDOR MAHO, ANIKO GERE, PAL VITTAY, EVA PALOSI, BELA KISS, GABOR BALOGH, ZOLTAN TUBA
Format Patent
LanguageEnglish
Published 06.01.1994
Edition5
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
STEROIDS
Online AccessGet full text

Cover

More Information
Summary:PCT No. PCT/HU93/00035 Sec. 371 Date Dec. 8, 1994 Sec. 102(e) Date Dec. 8, 1994 PCT Filed Jun. 8, 1993 PCT Pub. No. WO93/25570 PCT Pub. Date Dec. 23, 1993Novel, therapeutically active 21-aminosteroids of formula (I) (I) with pregnane skeleton, are disclosed wherein two of X, Y and Z are a nitrogen atom each and the third one is a methine group; R1 and R2 are independently from each other, a primary amino group bearing as substituent a branched-chain C4-8alkyl -alkenyl or -alkynyl group, or a C4-10cycloalkyl group comprising 1 to 3 ring(s) and being optionally substituted by at least one C1-3alkyl group; or R1 and R2 are each a spiro-heterocyclic secondary amino group containing at most 10 carbon atoms and optionally at least one oxygen atom as additional heteroatom; or one of R1 and R2 is an unsubstituted heterocyclic secondary amino group containing 4 to 7 carbon atoms and the other one is an above-identified primary amino group, an above-identified spiro-heterocyclic secondary amino group, or a heterocyclic secondary amino group containing 4 to 7 carbon atoms and substituted by at least one C1-4alkyl group; and n is 1 or 2, as well as their acid addition salts and pharmaceutical compositions containing these compounds.
Bibliography:Application Number: ZA19930004036